van der Wekken, A. J., Kok, K., & Groen, H. J. M. (2018). Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer? J Thorac Dis.
Chicago Style Citationvan der Wekken, Anthonie J., Klaas Kok, i Harry J. M. Groen. "Is Alectinib the New First Line Therapy in ALK-rearranged Advanced Non-small Cell Lung Cancer?" J Thorac Dis 2018.
Cita MLAvan der Wekken, Anthonie J., Klaas Kok, i Harry J. M. Groen. "Is Alectinib the New First Line Therapy in ALK-rearranged Advanced Non-small Cell Lung Cancer?" J Thorac Dis 2018.
Atenció: Aquestes cites poden no estar 100% correctes.